Ischemic Colitis Caused by Terlipressin during Treatment of Hepatorenal Syndrome / 대한내과학회지
Korean Journal of Medicine
;
: 406-409, 2016.
Artigo
em Coreano
| WPRIM
| ID: wpr-96327
ABSTRACT
Terlipressin, a vasopressin agonist, is widely used to treat variceal bleeding and hepatorenal syndrome in patients with liver cirrhosis. Terlipressin increases systemic vascular resistance, particularly in the splanchnic area, thus decreasing portal pressure. Although terlipressin is associated with a lower incidence of severe cardiovascular complications than is vasopressin, terlipressin can induce serious ischemic complications including myocardial infarction, skin necrosis, and bowel ischemia in < 1% of patients. We report the case of a 79-year-old female with liver cirrhosis treated with terlipressin to control hepatorenal syndrome that developed into ischemic colitis. The patient improved upon cessation of terlipressin and provision of supportive care.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Pele
/
Resistência Vascular
/
Síndrome Hepatorrenal
/
Vasopressinas
/
Varizes Esofágicas e Gástricas
/
Incidência
/
Pressão na Veia Porta
/
Colite Isquêmica
/
Isquemia
/
Cirrose Hepática
Tipo de estudo:
Estudo de incidência
/
Estudo prognóstico
Limite:
Idoso
/
Feminino
/
Humanos
Idioma:
Coreano
Revista:
Korean Journal of Medicine
Ano de publicação:
2016
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS